ACELYRIN, INC. Common Stock
SLRN
SLRN: Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates.
moreShow SLRN Financials
Recent trades of SLRN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SLRN's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on SLRN's company Twitter account
Number of mentions of SLRN in WallStreetBets Daily Discussion
Recent insights relating to SLRN
Recent picks made for SLRN stock on CNBC
ETFs with the largest estimated holdings in SLRN
Flights by private jets registered to SLRN